Details for 2021204155
Up to date per 04.04.2026
Actions
Details for 2021204155
Granted/Registered
European Patent
01.06.2022 A
12.10.2022 B1
06.07.2010
US
36182810 P
A61K 39/155 20060101AFI20220425BHEP
Owner
GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT
Inventor
GEALL, Andrew Emeryville, CA 94662-8097US
MANDL, Christian Emeryville, CA 94662-8097US
O'HAGAN, Derek Emeryville, CA 94662-8097US
SINGH, Manmohan Emeryville, CA 94662-8097US
Information about Fees